But HPV-mediated immune alteration analysis using The Cancer Genome Atlas shows that upregulation of TFRC may relate to a poor prognosis of survival of cervical cancer patients (Chen et al., 2018). The gene discussed is TFRC; the disease is cervical carcinoma.